Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (13)
Language
- English (13)
Keywords
- gene expression (3)
- thymus (2)
- Activation (1)
- B cell malignancies (1)
- Breast-cancer (1)
- CD/metabolism (1)
- CD40 ligand (1)
- Cancer (1)
- DNA hypermethylation (1)
- DNA methylation (1)
- Defined burkitts lymphoma (1)
- Expression (1)
- FFPE (1)
- Fak regulation (1)
- Gene-expression (1)
- Genome wide analysis (1)
- Hans algorithm (1)
- High-resolution (1)
- Histone deacetylase inhibition (1)
- Hodgkin lymphoma (1)
- Induced apoptosis (1)
- LESA (1)
- Lung-cancer (1)
- Lymph2Cx assay (1)
- MTCH2 (1)
- Mantle cell lymphoma (1)
- Mechanisms (1)
- Microarray (1)
- Migration (1)
- Molecular pathogenesis (1)
- Multiple (1)
- NF-Kappa-B (1)
- NGS (1)
- Nuclear expression (1)
- Pathogenesis (1)
- Phase- (1)
- Promoter (1)
- Rituximab plus (1)
- Riutximab (1)
- Sox9 (1)
- Stromal cells (1)
- Survival (1)
- T-cell lymphoma (1)
- Targets (1)
- Transcription-factor (1)
- abnormalities (1)
- amplifications (1)
- antigens (1)
- apoptosis (1)
- autoimmune disease (1)
- c-myc (1)
- cell of origin (1)
- cyclophsophamide (1)
- deletions (1)
- diagnostics (1)
- diffuse large B-cell lymphoma (1)
- distinct (1)
- flow cytometry (1)
- follicular lymphoma (1)
- gene regulation (1)
- genomic aberrations (1)
- grade 3B (1)
- growth patterns (1)
- high numbers (1)
- imaging (1)
- in-vitro (1)
- independent predictor (1)
- individual drug responses (1)
- lymphoma (1)
- machine learning (1)
- mantel cell lymphoma (1)
- marcophages (1)
- molecular subtypes (1)
- mouse xenografts (1)
- mutation (1)
- myasthenia (1)
- myasthenia gravis (1)
- ovarian tumor (1)
- panel-sequencing (1)
- pathology (1)
- perfusion culture (1)
- personalized medicine (1)
- poor prognosis (1)
- precision-cut tumor slices (1)
- preclinical model (1)
- prognostic factor (1)
- regulatory T-cells (1)
- relapse (1)
- surgery (1)
- survival (1)
- targeted (1)
- thymic carcinoma (1)
- thymic epithelial tumor (1)
- thymitis (1)
- thymoma (1)
- transformation (1)
- tumor heterogeneity (1)
- tumor microenvironment (1)
Thymic hyperplasia (TH) with lymphoepithelial sialadenitis (LESA)-like features (LESA-like TH) has been described as a tumor-like, benign proliferation of thymic epithelial cells and lymphoid follicles. We aimed to determine the frequency of lymphoma and autoimmunity in LESA-like TH and performed retrospective analysis of cases with LESA-like TH and/or thymic MALT-lymphoma. Among 36 patients (21 males) with LESA-like TH (age 52 years, 32–80; lesion diameter 7.0 cm, 1–14.5; median, range), five (14%) showed associated lymphomas, including four (11%) thymic MALT lymphomas and one (3%) diffuse large B-cell lymphoma. One additional case showed a clonal B-cell-receptor rearrangement without evidence of lymphoma. Twelve (33%) patients (7 women) suffered from partially overlapping autoimmune diseases: systemic lupus erythematosus (n = 4, 11%), rheumatoid arthritis (n = 3, 8%), myasthenia gravis (n = 2, 6%), asthma (n = 2, 6%), scleroderma, Sjögren syndrome, pure red cell aplasia, Grave’s disease and anti-IgLON5 syndrome (each n = 1, 3%). Among 11 primary thymic MALT lymphomas, remnants of LESA-like TH were found in two cases (18%). In summary, LESA-like TH shows a striking association with autoimmunity and predisposes to lymphomas. Thus, a hematologic and rheumatologic workup should become standard in patients diagnosed with LESA-like TH. Radiologists and clinicians should be aware of LESA-like TH as a differential diagnosis for mediastinal mass lesions in patients with autoimmune diseases.